<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Puerto Rico</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Puerto Rico.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/pr.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered concomitantly with routine pediatric vaccines in healthy infants and toddlers in USA and Puerto Rico: Results from a Phase III, randomized, active-controlled study.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1080-21645515-2026-2716508-f8e301e4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1080-21645515-2026-2716508-f8e301e4/</guid>
    <pubDate>Tue, 25 Aug 2026 00:00:00 GMT</pubDate>
    <description>Establishing the safety of this vaccine when combined with routine pediatric immunizations aids regulatory approval and clinical administration guidelines. The data contributes to understanding potential interactions within standard infant vaccination protocols.</description>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Pertussis</category>
    <category>Meningococcal disease</category>
    <category>Varicella</category>
    <category>Hepatitis B</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Cross-sectional analysis of chikungunya vaccine acceptability among residents of Ponce, Puerto Rico, 2024–2025</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128845-e5eb952d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128845-e5eb952d/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Identifying regional vaccination preferences enables health authorities to develop targeted educational campaigns that address safety inquiries and potentially increase immunization coverage during future arboviral events.</description>
    <category>Chikungunya</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Vaccine safety</category>
    <category>Cross-sectional study</category>
  </item>
  <item>
    <title>Increase in Travel-Associated and Locally Acquired Dengue Cases — United States, 2024</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7518a1-a851abde/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm7518a1-a851abde/</guid>
    <pubDate>Thu, 14 May 2026 00:00:00 GMT</pubDate>
    <description>The authors highlight the need for enhanced prevention, clinical awareness, and tailored public health messaging for travelers to dengue-endemic areas, given the marked increase in reported cases and associated hospitalizations and deaths.</description>
    <category>Dengue</category>
    <category>Surveillance</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
